Dr. Hsu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
54 Cascade Key
Bellevue, WA 98006Phone+1 650-515-8258
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Gastroenterology, 1989 - 1994
University of California San Francisco School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2004 Jun 01
- Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers Start of enrollment: 2006 Oct 01
- Safety Study of PLX4032 in Patients With Solid Tumors Start of enrollment: 2006 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 416 citationsRandomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial HypertensionVallerie V. McLaughlin, Ronald J. Oudiz, Adaani E. Frost, Victor F. Tapson, Srinivas Murali
American Journal of Respiratory and Critical Care Medicine. 2006-12-01 - 30 citationsA phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia.Catherine C. Smith, Mark J. Levis, Olga Frankfurt, John M. Pagel, Gail J. Roboz
Blood Advances. 2020-04-28 - 25 citationsPilot study of interferon gamma for chronic hepatitis C.Alejandro Soza, Theo Heller, Marc G. Ghany, Glen Lutchman, T. Jake Liang
Journal of Hepatology. 2005-07-01
Research History
- Howard Hughes Medical Institute Postdoctoral Research Fellow1992 - 1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
